We will be presenting at the Pharmaceutical Compliance Congress, April 25 – 27 at The Ritz-Carlton, Tysons Corner, McLean, VA

Our session addresses Best Price reporting matters relevant to the CMS Final Rule scheduled for implementation January 1, 2023.  Rick Ford will discuss emerging interpretations of compliance with the Final Rule and present the strategies which support mitigating Best Price exposure for affected drug brands.


Richard is a Fellow of the Life Management Association and a Self-insurance Certified Specialist with credentials in health plan benefit design. He holds BA and MBA degrees in economics and business management. His work experience includes roles as Vice President – Revenue Management with the specialty pharmacy division of major PBM’s, as well as senior roles with other pharmaceutical stakeholders.